IP Library › Granted Patent US 10,906,891
Granted Patent B2
US 10,906,891 · App. 16/109,931 · Granted Feb 2, 2021

Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide

Inventors: Ali Keshavarz-Shokri (San Diego, CA); Beili Zhang (San Diego, CA); Tim Edward Alcacio (San Diego, CA); Elaine Chungmin Lee (Arlington, MA); Yuegang Zhang (Wayland, MA); Mariusz Krawiec (Marlborough, MA)
Assignee: Vertex Pharmaceuticals Incoporated
C07D405/12A61K31/404A61K31/47A61K31/4709A61K45/06C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,906,891
App. No.
16/109,931
Granted
Feb 2, 2021
Kind
B2
Abstract

The present invention relates to solid forms of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (Compound 1) in substantially crystalline form (Form A) or amorphous form, pharmaceutical compositions thereof, and methods of treatment therewith.

Claims (16)

1. A process of preparing amorphous (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide comprising spray drying (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide.

2. The process of claim 1 , comprising combining (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide and a suitable solvent and then spray drying the mixture to obtain amorphous (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide.

3. The process of claim 2 , wherein the solvent is an alcohol.

4. The process of claim 2 , wherein the solvent is methanol.

5. The process of claim 1 , comprising:

a) forming a mixture comprising (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide, a polymer, and a solvent; and

b) spray drying the mixture to form a solid dispersion.

6. The process of claim 5 , wherein the polymer is hydroxypropylmethylcellulose acetate succinate (HPMCAS).

7. The process of claim 5 , wherein the polymer is in an amount of from 10% by weight to 80% by weight of the solid dispersion.

8. The process of claim 5 , wherein the polymer is in an amount of about 49.5% by weight of the solid dispersion.

9. The process of claim 5 , wherein the solvent is methanol.

10. The process of claim 5 , wherein the mixture further comprises a surfactant.

11. The process of claim 6 , wherein the surfactant is sodium lauryl sulfate (SLS).

12. The process of claim 10 , wherein the surfactant is in an amount of from 0.1% by weight to 5% by weight of the solid dispersion.

13. The process of claim 10 , wherein the surfactant is in an amount of about 0.5% by weight of the solid dispersion.

14. The process of claim 5 , wherein the polymer is hydroxypropylmethylcellulose acetate succinate (HPMCAS) in the amount of about 49.5% by weight of the solid dispersion, the solvent is methanol, and the mixture further comprises sodium lauryl sulfate in an amount of about 0.5% by weight of the solid dispersion.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2019
From: LEE, ELAINE CHUNGMIN; ZHANG, YUEGANG; KRAWIEC, MARIUSZ
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 049264/0239 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2019
From: KESHAVARZ-SHOKRI, ALI; ZHANG, BEILI; ALCACIO, TIM EDWARD
To: VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
Reel/Frame 049264/0482 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2019
From: VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 049264/0511 →
CHANGE OF ADDRESS Recorded May 23, 2019
From: VERTEX PHARMACEUTICALS INCORPORATED
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 049265/0817 →
Continuity (9)
Division 14676205 · Apr 1, 2015
Continuation 14318131 · Jun 27, 2014
Continuation 13624241 · Sep 21, 2012
Continuation PCTUS2011030032 · Mar 25, 2011
Provisional Application 61321561 · Apr 7, 2010
Provisional Application 61321636 · Apr 7, 2010
Provisional Application 61319953 · Apr 1, 2010
Provisional Application 61317376 · Mar 25, 2010
Related Publication 20190270728A1 · Sep 5, 2019
Cited By (6)
US 50,453 US 12,214,083 US 12,269,831 US 12,324,802 US 12,458,635 US 12,508,231